Medication info

Magmega Injection (Magnesium Sulfate Heptahydrate)

Prescription medicationIntramuscular injection · Intravenous injection
Ingredient · strength
Magnesium Sulfate Hydrate›0.1g / 1mL
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
Colorless liquid in a transparent plastic (polypropylene, polyethylene) container
Packaging
50 ampoules/box [(20 milliliters/plastic ampoule x 50)]
Approval status
Active

MFDS item code 202201794 · Notified 2022.05.03

Summary

Main use
Correction of hypomagnesemia; suppression of hypomagnesemic seizures and eclamptic seizures; prevention of uterine rigidity
Who receives it
Adults · Children
Adult administration
○ Convulsions due to hypomagnesemia: Administer 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Seizures of eclampsia: Administer 4 ∼ 5 g of this medicine intravenously over 10 minutes (16.2 ∼ 20.25 mmol) ○ Prevention of uterine rigidity: Initially administer 4 g of this medicine intravenously (16.2 mmol). Thereafter, 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Administer 1 g of this medicine intramuscularly every 6 hours for 4 doses. Alternatively, 5 g of this medicine may be added to 5 % dextrose injection or 0.9 % normal saline injection and administered intravenously over 3 hours. During treatment of the deficiency, the patient's renal excretory function should be monitored closely.
Child administration
○ Children: The safety of this medicine has not been studied.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Correction of hypomagnesemia; suppression of hypomagnesemic seizures and eclamptic seizures; prevention of uterine rigidity

  • Convulsions due to hypomagnesemia
  • seizures of eclampsia
  • uterine rigidity
View approved original text

This medication is used to prevent convulsions due to hypomagnesemia or seizures caused by eclampsia, and to prevent excessive uterine contractions. It also supplements magnesium deficiency caused by hypomagnesemia to improve electrolyte balance. This helps relieve the patient's symptoms and maintain health.

How it is given

Adult administration

○ Convulsions due to hypomagnesemia: Administer 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Seizures of eclampsia: Administer 4 ∼ 5 g of this medicine intravenously over 10 minutes (16.2 ∼ 20.25 mmol) ○ Prevention of uterine rigidity: Initially administer 4 g of this medicine intravenously (16.2 mmol). Thereafter, 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Administer 1 g of this medicine intramuscularly every 6 hours for 4 doses. Alternatively, 5 g of this medicine may be added to 5 % dextrose injection or 0.9 % normal saline injection and administered intravenously over 3 hours. During treatment of the deficiency, the patient's renal excretory function should be monitored closely.

Child administration

○ Children: The safety of this medicine has not been studied.

Precautions

This medication is a glass ampoule injectable product; therefore, glass fragments may contaminate when opening the container, requiring utmost care during use. Special caution is necessary when administering to children or the elderly. This drug should not be used in patients with poor kidney function, patients in a coma, patients with high blood magnesium levels, patients with cardiac conduction disorders, and patients with myasthenia gravis. Special caution should also be exercised when administering this drug to children with intestinal parasitic diseases or patients with heart conditions. Using this drug may result in gastrointestinal symptoms such as vomiting or dry mouth, and rarely, cardiac side effects such as conduction disorders or bradycardia may occur. Symptoms of autonomic nervous system involvement such as headache, heaviness, tremors, and tingling may also be reported. Overdose can lead to magnesium toxicity, with serious symptoms like a sense of heat, thirst, hypotension, central nervous system depression, cardiac suppression, and respiratory failure. In this case, calcium supplements should be administered intravenously for detoxification treatment. This drug may interact with other medications, so special caution is required, especially when used with central nervous system depressants, as their effects may be enhanced. Additionally, co-administration with iron supplements, certain antibiotics, or sodium fluoride may reduce the absorption of those drugs. This medication is used for the treatment of eclampsia during pregnancy but can cause decreased muscle tone or respiratory depression in the fetus, so fetal condition should be closely monitored. When administered during delivery, there is a risk of respiratory depression in the newborn; therefore, it is advisable not to use it within 2 hours post-delivery. Prolonged administration during pregnancy may affect fetal calcium and skeletal development, so it should be used cautiously. The safety of this drug during breastfeeding has not been established, and it is recommended not to use it unless absolutely necessary. The elderly may have decreased physiological function, so it is necessary to adjust the dosage and administer it slowly. In cases of overdose, serious symptoms such as arrhythmias, decreased consciousness, and respiratory depression may appear, and immediate cessation of administration and appropriate treatment should be obtained. When given intravenously, it should be injected slowly at concentrations less than 10% and should not be mixed with this drug and certain formulations to avoid precipitation. To prevent infection during administration, skin and instruments should be disinfected, and any remaining medication should not be reused after opening.

Side effects

  • vomiting
  • dry mouth
  • conduction disorder
  • bradycardia
  • flushing
  • peripheral vascular dilation
  • headache
  • heaviness
  • tremors
  • tingling
Show 7 more
  • warmth sensation
  • thirst
  • hypotension
  • central nervous system suppression
  • heart rate reduction
  • respiratory paralysis
  • warmth sensation at the injection site

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air, ideally at room temperature between 1 to 30 degrees Celsius. This storage preserves the medication's efficacy and prevents deterioration.

Appearance and packaging

Appearance

Colorless liquid in a transparent plastic (polypropylene, polyethylene) container

Package unit

50 ampoules/box [(20 milliliters/plastic ampoule x 50)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.